Synjardy 500 mg/1

Synjardy 500 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan. Ideal for those seeking effective diabetes management.

Synjardy 500 mg/1 tablets are designed to help manage type 2 diabetes by improving blood sugar levels. This combination medication works by enhancing the body's response to insulin and reducing glucose absorption in the kidneys. It is often used alongside diet and exercise for comprehensive diabetes care.

Common effects of Synjardy 500 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some users might experience low blood sugar levels, especially when combined with other diabetes medications. Always monitor your body's response and consult a healthcare provider if effects are concerning.

Handle Synjardy 500 mg/1 tablets with care, especially if you have kidney issues or are prone to low blood sugar. Avoid alcohol while using this medication, as it can increase the risk of side effects. Store the tablets in a cool, dry place away from direct sunlight.

Synjardy 500 mg/1 tablets may interact with other diabetes medications, diuretics, and certain antibiotics. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Be cautious with alcohol, as it can exacerbate side effects.